| |
| |
|
| Insider
Information: |
Wong Roderick |
| Relationship: |
10% Owner |
| City: |
Patterson |
| State: |
NY |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
15 |
|
| Direct
Shares |
0 |
|
|
Indirect Shares
|
57,532,221 |
|
|
| Direct
Value |
$0 |
|
|
|
Indirect Value
|
$1,236,989,884 |
|
|
| Total
Shares |
57,532,221 |
|
|
| Total
Value |
$1,236,989,884 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
6
|
0
|
|
Stock
price went up :
|
3
|
0
|
| Stock
price went down : |
3
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
 13.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Penwest Pharmaceuticals Co |
PPCO |
Director |
2010-09-20 |
0 |
2010-06-30 |
0 |
Premium* |
|
|
Milestone Pharmaceuticals Inc. |
MIST |
10% Owner |
2019-05-09 |
0 |
2023-03-22 |
3,256,102 |
Premium* |
|
|
Stoke Therapeutics, Inc. |
STOK |
10% Owner |
2019-06-19 |
0 |
2019-11-08 |
3,544,248 |
Premium* |
|
|
Dermtech Ord Shs |
DMTK |
10% Owner |
|
0 |
2022-11-04 |
3,018,666 |
Premium* |
|
|
Immunovant Inc |
IMVT |
Chief Executive Office... |
2019-11-07 |
0 |
2019-12-11 |
902,498 |
Premium* |
|
|
Tela Bio, Inc. |
TELA |
10% Owner |
2019-12-13 |
0 |
2019-12-17 |
1,139,358 |
Premium* |
|
|
Avidity Biosciences, Inc. |
RNA |
MP and CIO |
2020-06-16 |
0 |
2021-08-04 |
4,795,000 |
Premium* |
|
|
Athira Pharma, Inc. |
ATHA |
10% Owner |
|
0 |
2020-09-18 |
2,668,913 |
Premium* |
|
|
Tarsus Pharmaceuticals, Inc. |
TARS |
10% Owner |
|
0 |
2021-05-07 |
2,013,601 |
Premium* |
|
|
Landos Biopharma, Inc. |
LABP |
10% Owner |
2021-02-04 |
0 |
2022-09-23 |
3,975,722 |
Premium* |
|
|
Prometheus Biosciences, Inc. |
RXDX |
10% Owner |
2021-03-16 |
0 |
2021-03-16 |
3,264,031 |
Premium* |
|
|
Renovacor Ord Shs |
RCOR |
10% Owner |
2021-09-02 |
0 |
2022-12-01 |
0 |
Premium* |
|
|
Orchestra BioMed Holdings Inc. |
OBIO |
10% Owner |
2022-07-22 |
0 |
2023-04-13 |
5,620,645 |
Premium* |
|
|
Rocket Pharmaceuticals |
RCKT |
Director, 10% Owner |
2022-10-06 |
0 |
2023-08-28 |
18,157,605 |
Premium* |
|
|
Cargo Therapeutics, Inc. |
CRGX |
10% Owner |
|
0 |
2024-01-12 |
5,175,832 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
93 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 4
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| DMTK |
Dermtech Ord Shs |
10% Owner |
– – • |
2019-08-29 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
2,386,871 |
|
- |
|
| TELA |
Tela Bio, Inc. |
10% Owner |
– – • |
2019-12-11 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
1,151,458 |
|
- |
|
| ATHA |
Athira Pharma, Inc. |
10% Owner |
– – • |
2020-09-17 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
383,782 |
|
- |
|
| TARS |
Tarsus Pharmaceuticals, I... |
10% Owner |
– – • |
2020-10-16 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
2,463,601 |
|
- |
|
| CRGX |
Cargo Therapeutics, Inc. |
10% Owner |
– – • |
2023-11-14 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
5,175,832 |
|
- |
|
| PPCO |
Penwest Pharmaceuticals C... |
Director |
– • – |
2010-06-30 |
4 |
A |
$0.00 |
$0 |
D/D |
20,000 |
20,000 |
0 |
- |
|
| PPCO |
Penwest Pharmaceuticals C... |
Director |
– • – |
2010-09-20 |
4 |
D |
$0.00 |
$0 |
D/D |
(20,000) |
0 |
0 |
- |
|
| MIST |
Milestone Pharmaceuticals... |
10% Owner |
– – • |
2019-05-09 |
4 |
A |
$0.00 |
$0 |
I/I |
2,855,189 |
2,855,189 |
0 |
- |
|
| STOK |
Stoke Therapeutics, Inc. |
10% Owner |
– – • |
2019-06-19 |
4 |
A |
$0.00 |
$0 |
I/I |
2,799,910 |
2,799,910 |
0 |
- |
|
| DMTK |
Dermtech Ord Shs |
10% Owner |
– – • |
2020-05-27 |
4 |
A |
$0.00 |
$0 |
I/I |
228,498 |
2,855,766 |
0 |
- |
|
| RNA |
Avidity Biosciences, Inc. |
Director |
– • • |
2020-06-16 |
4 |
A |
$0.00 |
$0 |
I/I |
3,045,000 |
3,045,000 |
0 |
- |
|
| ATHA |
Athira Pharma, Inc. |
10% Owner |
– – • |
2020-09-18 |
4 |
A |
$0.00 |
$0 |
I/I |
1,535,131 |
1,918,913 |
0 |
- |
|
| LABP |
Landos Biopharma, Inc. |
Director |
– • • |
2021-02-08 |
4 |
A |
$0.00 |
$0 |
I/I |
3,650,722 |
4,275,722 |
0 |
- |
|
| RXDX |
Prometheus Biosciences, I... |
10% Owner |
– – • |
2021-03-16 |
4 |
A |
$0.00 |
$0 |
I/I |
2,464,031 |
3,264,031 |
0 |
- |
|
| RCOR |
Renovacor Ord Shs |
10% Owner |
– – • |
2022-12-01 |
4 |
D |
$0.00 |
$0 |
I/I |
(3,000,803) |
0 |
0 |
- |
|
| RCKT |
Rocket Pharmaceuticals |
Director |
– • • |
2022-12-01 |
4 |
A |
$0.00 |
$0 |
I/I |
529,038 |
18,157,605 |
0 |
- |
|
| OBIO |
Orchestra BioMed Holdings... |
10% Owner |
– – • |
2023-01-26 |
4 |
A |
$0.00 |
$0 |
I/I |
2,310,000 |
5,118,512 |
0 |
- |
|
| MIST |
Milestone Pharmaceuticals... |
10% Owner |
– – • |
2023-03-22 |
4 |
D |
$0.00 |
$0 |
I/I |
(1,059,000) |
3,256,102 |
0 |
- |
|
| OBIO |
Orchestra BioMed Holdings... |
10% Owner |
– – • |
2023-04-13 |
4 |
A |
$0.00 |
$0 |
I/I |
502,133 |
5,620,645 |
0 |
- |
|
| CRGX |
Cargo Therapeutics, Inc. |
10% Owner |
– – • |
2024-01-12 |
4 |
D |
$0.00 |
$0 |
I/I |
(1,842,499) |
5,175,832 |
0 |
- |
|
| RCOR |
Renovacor Ord Shs |
10% Owner |
– – • |
2022-01-13 |
4 |
B |
$7.75 |
$2,217 |
I/I |
286 |
2,805,640 |
1.42 |
- |
|
| MIST |
Milestone Pharmaceuticals... |
10% Owner |
– – • |
2019-10-10 |
4 |
B |
$16.00 |
$2,864 |
I/I |
179 |
3,530,185 |
1.42 |
- |
|
| RCOR |
Renovacor Ord Shs |
10% Owner |
– – • |
2022-01-12 |
4 |
B |
$7.67 |
$14,957 |
I/I |
1,950 |
2,805,354 |
1.5 |
- |
|
| MIST |
Milestone Pharmaceuticals... |
10% Owner |
– – • |
2019-10-15 |
4 |
B |
$18.00 |
$19,800 |
I/I |
1,100 |
3,535,493 |
1.5 |
- |
|
| MIST |
Milestone Pharmaceuticals... |
10% Owner |
– – • |
2019-12-30 |
4 |
B |
$15.48 |
$20,638 |
I/I |
1,333 |
3,936,826 |
1.5 |
- |
|
93 Records found
|
|
Page 1 of 4 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
